Literature DB >> 8374213

Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K.

E A Cornelissen1, L A Kollée, R A De Abreu, K Motohara, L A Monnens.   

Abstract

Vitamin K prophylaxis has been developed to prevent classic haemorrhagic disease of the newborn. Single vitamin K administration after birth has been reported to fail, resulting in late haemorrhagic disease of the newborn. The preventive effect of oral administration of vitamin K1 1 mg, repeated weekly during the first three months of life, was studied in 48 healthy breast-fed infants, by determination of thrombotest, PIVKA-II and vitamin K1 concentrations at the age of 4, 8 and 12 weeks. All infants showed normal thrombotest values and PIVKA-II was not detectable. Vitamin K1 concentrations were negatively correlated with the number of days elapsed since the most recent vitamin K administration. Six to seven days after the latest application, mean levels were 1223, 927 and 748 pg/ml at ages 4, 8 and 12 weeks, respectively. In conclusion, weekly administration of vitamin K1 1 mg offers complete protection against vitamin K deficiency and does not result in an accumulation of vitamin K1 in the blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374213     DOI: 10.1111/j.1651-2227.1993.tb18034.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  Unlicensed and off label drug use in neonates.

Authors:  S Conroy; J McIntyre; I Choonara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

Review 2.  Oral versus intramuscular phytomenadione: safety and efficacy compared.

Authors:  R von Kries
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

3.  Controversies surrounding the administration of vitamin K to newborns: a review.

Authors:  M A Brousson; M C Klein
Journal:  CMAJ       Date:  1996-02-01       Impact factor: 8.262

Review 4.  Vitamin K in neonates: how to administer, when and to whom.

Authors:  E Autret-Leca; A P Jonville-Béra
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

Review 5.  Assessment of Micronutrient Status in Critically Ill Children: Challenges and Opportunities.

Authors:  Duy T Dao; Lorenzo Anez-Bustillos; Bennet S Cho; Zhilling Li; Mark Puder; Kathleen M Gura
Journal:  Nutrients       Date:  2017-10-28       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.